XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Revenues        
Product revenue, net $ 15,147,034 $ 3,175,236 $ 28,667,280 $ 4,615,062
Operating expenses        
Cost of sales 5,998,389 606,046 9,817,545 981,766
Research and development 286,572 66,675 469,437 144,695
Selling, general and administrative 12,852,614 6,516,160 24,342,983 11,662,603
Amortization of intangible assets 1,584,580 953,450 3,169,161 1,528,567
Total operating expenses 20,722,155 8,142,331 37,799,126 14,317,631
Loss from operations (5,575,121) (4,967,095) (9,131,846) (9,702,569)
Other (expense) income        
Other (expense), net (378,958) (446,958) (1,130,499) (642,344)
Loss from change in fair value of contingent consideration (3,313,656) (2,411,333)
Gain from derecognition of contingent consideration 5,199,806 5,199,806
Gain from warrant derivative liability 1,830
Loss on debt exchange (257,559) (257,559)
Total other (expense) income (3,950,173) 4,752,848 (4,699,378) 4,559,292
Net loss $ (9,525,294) $ (214,247) $ (13,831,224) $ (5,143,277)
Weighted average number of common shares outstanding (in shares) 13,281,904 1,753,815 12,717,180 1,642,599
Basic and diluted net loss per common share (in dollars per share) $ (0.72) $ (0.12) $ (1.09) $ (3.13)